Global Viral Vector Manufacturing Market Analysis, Trends, and Forecasts 2019-2025

Thursday, 03. October 2019 11:10

Dublin, Oct. 03, 2019 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Viral Vector Manufacturing market worldwide is projected to grow by US$860 Million, driven by a compounded growth of 20.6%.

Retroviral Vectors, one of the segments analyzed and sized in this study, displays the potential to grow at over 18.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$364.1 Million by the year 2025, Retroviral Vectors will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 22.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$32.7 Million to the region's size and clout in the next 5 to 6 years. Over US$57.6 Million worth of projected demand in the region will come from other emerging Eastern European markets.

In Japan, Retroviral Vectors will reach a market size of US$30.7 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 20.2% over the next couple of years and add approximately US$150.8 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include the following, among others:

  • Cell and Gene Therapy Catapult (United Kingdom)
  • Cobra Biologics (United Kingdom)
  • FujiFilm Diosynth Biotechnologies U.S.A., Inc. (USA)
  • Lonza Group AG (Switzerland)
  • Merck KgaA (Germany)
  • Oxford Biomedica plc (United Kingdom)
  • Spark Therapeutics, Inc. (USA)
  • uniQure NV (The Netherlands)

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Viral Vector Manufacturing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Global Competitor Market Shares by Segment
  • Retroviral Vectors (Type) Global Competitor Market Share Positioning for 2019 & 2025
  • Adenoviral Vectors (Type) Market Share Breakdown of Key Players: 2019 & 2025
  • Adeno-associated Viral Vectors (Type) Competitor Revenue Share (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

  • Market Facts & Figures
  • US Viral Vector Manufacturing Market Share (in %) by Company: 2019 & 2025
  • Retroviral Vectors (Type) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025
  • Adenoviral Vectors (Type) Competitor Revenue Share (in %) in the US: 2019 & 2025
  • Adeno-associated Viral Vectors (Type) Market Share Breakdown (in %) of Major Players in the US: 2019 & 2025

CANADA

JAPAN

CHINA

EUROPE

  • Market Facts & Figures
  • European Viral Vector Manufacturing Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Retroviral Vectors (Type) Market Share (in %) by Company in Europe: 2019 & 2025
  • Adenoviral Vectors (Type) Market Share (in %) of Major Players in Europe: 2019 & 2025
  • Adeno-associated Viral Vectors (Type) Competitor Market Share Analysis (in %) in Europe: 2019 & 2025

FRANCE

GERMANY

ITALY

UNITED KINGDOM

REST OF EUROPE

ASIA-PACIFIC

REST OF WORLD

IV. COMPETITION

V. CURATED RESEARCH

For more information about this report visit https://www.researchandmarkets.com/r/t1042b

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Primary Logo

Related Links: 
Author:
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.